BOTHELL, Wash.--(BUSINESS WIRE)--Cardiac Science Corporation (NASDAQ: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced revenue for the quarter ended September 30, 2008 of $54.0 million, an increase of 20% over the prior year period.
